Compounds > dacarbazine

dacarbazine and concanavalin a

dacarbazine has been researched along with concanavalin a in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gelfi, P; Marelli, O; Nicolin, A; Nicolotti, G1
Conti, AM; Marelli, O; Nicolin, A1
Chaitchik, S; Eisenthal, A; Ron, I; Skornick, Y; Zakuth, V1
Hirano, T; Onda, K; Sugiyama, K; Tanaka, S; Tohyama, N1

Other Studies

4 other study(ies) available for dacarbazine and concanavalin a

ArticleYear
Con A agglutination of DTIC-altered lymphoma cells.
    Pharmacological research communications, 1978, Volume: 10, Issue:4

    Topics: Adsorption; Agglutination; Animals; Cells, Cultured; Concanavalin A; Dacarbazine; Female; Leukemia L1210; Lymphoma; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Triazenes

1978
Immunological and cytogenetic characterization of lymphocitic mouse leukemias after treatment with antineoplastic drugs.
    Pharmacological research communications, 1978, Volume: 10, Issue:10

    Topics: Agglutination Tests; Animals; Antineoplastic Agents; Chromosomes; Concanavalin A; Cyclophosphamide; Dacarbazine; DNA, Neoplasm; Female; Leukemia, Experimental; Male; Mice; Mice, Inbred DBA; Phytohemagglutinins

1978
Phenotypic and functional profile of peripheral blood mononuclear cells isolated from melanoma patients undergoing combined immunotherapy and chemotherapy.
    Cancer immunology, immunotherapy : CII, 1993, Volume: 37, Issue:6

    Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Division; Chemotherapy, Adjuvant; Concanavalin A; Dacarbazine; Dose-Response Relationship, Drug; Female; Humans; Immunophenotyping; Immunotherapy; Interferon Type I; Interleukin-2; Killer Cells, Lymphokine-Activated; Leukocytes, Mononuclear; Male; Melanoma; Middle Aged; Phytohemagglutinins; Pokeweed Mitogens; Recombinant Proteins

1993
Influence of anticancer agents on cell survival, proliferation, and CD4+CD25+Foxp3+ regulatory T cell-frequency in human peripheral-blood mononuclear cells activated by T cell-mitogen.
    International immunopharmacology, 2013, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Proliferation; Cell Survival; Concanavalin A; Cytokines; Dacarbazine; Female; Fluorouracil; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Male; Methotrexate; Mitogens; Oxides; T-Lymphocytes, Regulatory; Young Adult

2013